Canbud Subsidiary, Molecular Science Corp., Receives Dealer’s License – Becomes One of Very Few Organizations Able To Work With Psilocybin with Health Canada Approval

Toronto, Ontario–(Newsfile Corp. – August 3, 2021) – Canbud Distribution Corp. (CSE: CBDX) (“Canbud” or the “Corporation”) is pleased to announce that its wholly-owned subsidiary, Molecular Science Corp. (“MSC” or the “Company“), a leading GMP analytical services company, has received its Dealer’s License from Health Canada on July 30, 2021. As a result, MSC has become one of very few organizations able to work with Psilocybin with Health Canada approval….

Click here to read the full press release: https://www.newsfilecorp.com/release/91934/Canbud-Subsidiary-Molecular-Science-Corp.-Receives-Dealers-License-Becomes-One-of-Very-Few-Organizations-Able-To-Work-With-Psilocybin-with-Health-Canada-Approval